(3AR,4R,5R,6AS)-4-[(E,3S)-3-HYDROXY-5-PHENYLPENT-1-ENYL]-3,3A,4,5,6,6A-HEXAHYDRO-2H-CYCLOPENTA[B]FURAN-2,5-DIOL(CAS: 856240-62-5)

This compound, also known as Bimatoprost Impurity, is a cyclic ether derivative with a unique molecular structure. It contains a cyclopentane-furan ring system and is a derivative of the drug bimatoprost, used in the treatment of glaucoma and ocular hypertension.

This compound is primarily used as an impurity in the manufacturing of bimatoprost, a topical medication for glaucoma and ocular hypertension. It is not used as a standalone therapeutic agent but is carefully monitored and controlled during the production process.

While this compound is generally safe when used as an impurity in the pharmaceutical production process, it is important to follow safety guidelines. Proper handling, storage, and disposal procedures should be adhered to, and appropriate personal protective equipment should be used to minimize exposure risks.

This compound should be stored in a cool, dry place away from direct sunlight and heat. It should be kept in a tightly sealed container to prevent degradation. Optimal storage conditions include a temperature range of 15-25°C (59-77°F) and a relative humidity below 60% to ensure stability and minimize the risk of degradation.